Home › Funds › Stonepine Capital Management, LLC › KTTA
Stonepine Capital Management, LLC position in KTTA
PASITHEA THERAPEUTICS CORP · Health Care
Stonepine Capital Management, LLC reported holding 2,774,234 shares of KTTA (PASITHEA THERAPEUTICS CORP) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 1.05% of its reported portfolio and ranking #23 among its reported holdings. Stonepine Capital Management, LLC has disclosed KTTA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Stonepine Capital Management, LLC's KTTA position evolved
Stonepine Capital Management, LLC first disclosed a stake in KTTA in Q4 2025 at 275,062 shares (US$355K). The position peaked in Q3 2026 at 2,774,234 shares, worth US$1.4M. Across 4 filings, Stonepine Capital Management, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,774,234 shares valued at US$1.4M — an increase of 572,766 shares quarter over quarter.. Notable position changes include a 202% increase in Q1 2026 (shares fell 31% over the following quarter), a 165% increase in Q2 2026 (shares fell 4% over the following quarter), a 26% increase in Q3 2026 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 275.06K | $354.83K | New |
| Q1 2026 | 831.30K | $616.66K | Add |
| Q2 2026 | 2.20M | $1.13M | Add |
| Q3 2026 | 2.77M | $1.37M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KTTA and 13F data
KTTA (PASITHEA THERAPEUTICS CORP) is a Health Care company. 27 other funds we track also report a position in KTTA — the largest reported positions include Squadron Capital Management LLC (US$515K), Vivo Capital, LLC (US$184K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KTTA
- Squadron Capital Management LLC 1.00M sh · $515.40K · Q2 2026
- Vivo Capital, LLC 372.80K sh · $183.79K · Q3 2026
More on Stonepine Capital Management, LLC
FAQ
How long has Stonepine Capital Management, LLC held KTTA?
Stonepine Capital Management, LLC has disclosed KTTA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Stonepine Capital Management, LLC's current position in KTTA?
As of Q3 2026, Stonepine Capital Management, LLC holds 2.77M shares of KTTA (PASITHEA THERAPEUTICS CORP), valued at $1.37M, representing 1.05% of its reported portfolio and ranking #23.
Has Stonepine Capital Management, LLC been buying or selling KTTA?
In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC increased its position in KTTA. The position peaked in Q3 2026 at 2.77M shares.
Which other funds hold KTTA?
Other major institutional holders of KTTA include Squadron Capital Management LLC, Vivo Capital, LLC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.